EXPLORING BETULINIC ACID: A PROMISING THERAPY FOR ASTHMA IN MALE MICE

Authors

  • Sher Afghan Khan Department of Pharmacology, Gajju Khan Medical College, Swabi, Pakistan https://orcid.org/0009-0009-7254-0536
  • Qadeer Nawaz Department of Pharmacology, Gajju Khan Medical College, Swabi, Pakistan https://orcid.org/0009-0003-9451-3324
  • Muhammad Tahir Department of Pharmacology, Mekran Medical College, Turbat, Pakistan
  • Sameer Ahmed Department of Pharmacology, Rawal Institute of Health Sciences, Rawalpindi, Pakistan
  • Muhammad Junaid Khan Final Year MBBS Student, Gajju Khan Medical College Swabi, Pakistan
  • Saqib Zaman Pharmacist, Baja, Swabi, Pakistan

DOI:

https://doi.org/10.69656/pjp.v20i4.1725

Keywords:

Betulinic acid, Dexamethasone,, Ovalbumin, Immunomodulatory, Interleukin

Abstract

Background: Betulinic acid (BA) has been proven to contain diverse functions such as anti-cancer effects, anti-HIV, anti-bacterial, anti-inflammatory, anti-malarial, anti-helminthic, and other pharmaceutical properties. The objective of this study was to assess the immunomodulatory effects of BA on ovalbumin induced airway inflammation in male mice. Methods: Forty healthy BALB/c mice were randomly divided into 4 groups. Group I served as normal control (NC) group. Group II as asthmatic control (AC) group and was sensitized intraperitoneally (IP) with ovalbumin (OVA) at day 0 and challenged at day 14 respectively and from day 15 to 21 was challenged intranasally (I/N) for one week. Group III were treated with OVA (I/N) and concomitantly BA at 5 mg/Kg body weight was given orally, and Group IV were treated with OVA (I/N) and concomitantly dexamethasone (DEX) 2 mg/Kg body weight was given orally for 7 days. Terminal sampling at day 22 was performed for blood TLC and DLC and lung tissue sampling for interleukin 4 by mRNA expression. Results: Betulinic acid significantly lowered both the differential cell count of blood and the mRNA expression of IL-4 in asthmatic model of mice. Conclusion: Betulinic acid manifested similar results when compared to DEX in lowering the pro-inflammatory markers.

Pak J Physiol 2024;20(4):40-3, DOI: https://doi.org/10.69656/pjp.v20i4.1725

Downloads

Download data is not yet available.

References

Yakubu A. Conceptualizing the maturity of citizens for consumer health informatics in low and middle-income countries empirical analysis of Chile, Ghana, Iraq, Kosovo, Turkey, and Ukraine (Doctoral dissertation). Heidelberg: 2023.

Samans R. Human-centred national economic policy: Institutionalizing inclusion, sustainability and resilience in domestic economic governance. In: Human-centred economics: The living standards of nations. Cham: Springer International Publishing; 2023.p. 131–234).

Soomro RN, Rohi S, Tabasum A. Prevalence of asthma and allergen in Bolan Medical Complex and Sendeman provincial tertiary care hospitals Quetta Balochistan. Mader-e-Milat Int J Nurs Allied Sci 2024;2(1):63–79.

Nguyen GT, Gauvreau C, Mansuri N, Wight L, Wong B, Neposlan J, et al. Implementation factors of non-communicable disease policies and programmes for children and youth in low-income and middle-income countries: a systematic review. BMJ Paediatrics Open 2024;8(1):e002556.

Muralitharan M. The Impact of Race on the Health of South Asians: A Systematic Review. (Doctoral dissertation). McMaster University; 2023. Available from: http://hdl.handle.net/11375/ 29126.

Urs RC, Evans DJ, Bradshaw TK, Gibbons JTD, Smith EF, Foong RE, et al. Inhaled corticosteroids to improve lung function in children (aged 6–12 years) who were born very preterm (PICSI): a randomised, double-blind, placebo-controlled trial. Lancet Child Adolesc Health 2023;7(8):567–76.

Matsumura Y. Inadequate therapeutic responses to glucocorticoid treatment in bronchial asthma. J Int Med Res 2023;51(6):03000605231175746.

Rai JP, Sahi MA, Prajapati M, Verma S, Parthiban MS. Text book of Pharmacology I: Bilaspur: Shashwat Publication; 2024.

Dejaco C, Kerschbaumer A, Aletaha D, Bond M, Hysa E, Camellino D, et al. Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica. Ann Rheum Dis 2024;83(1):48–57.

Harker JA, Lloyd CM. T helper 2 cells in asthma. J Exp Med 2023;220(6):e20221094.

Sen HN. Elements of the immune system and concepts of intraocular inflammatory disease pathogenesis. In: Scott M. Whitcup, H. Nida Sen. (Eds). Whitcup and Nussenblatt’s Uveitis: Fundamentals and Clinical Practice. Elsevier; 2021.p.1–28.

Kaboodkhani R, Mehrabani D, Karimi-Busheri F. Achievements and challenges in transplant ation of mesenchymal stem cells in otorhinolaryngology. J Clin Med 2021;10(13):2940.

Pereira LCC, Coelho JWR, Elidio HDSM, Silva RCPF, Sobral JGR, Soledade BAB, et al. Clinical/behavioral monitoring of rodents and rabbits undergoing scientific experiments. Open J Vet Med 2024;14(5):91–109.

Pimenta BL, Menezes TP, Louise V, Dias FCR, Machado BAA, Ribeiro L, et al. Protective effects of Theracurmin treatment during experimental infection of the Colombian strain of Trypanosoma cruzi at the testicular site. Front Cell Infect Microbiol 2023;13:1143360.

Rizzo GP, Sanches RC, Chavero C, Bianchi DS, Apuzzo E, Herrera SE, et al. Poly(allylamine)/tripolyphosphate nanocomplex coacervate as a NLRP3-dependent systemic adjuvant for vaccine development. bioRxiv [Preprint] 2024:2024.07.01.601578.

Hussein NA, Gawad HS, Maklad HM, El-Fakharany EM, Aly RG, Samy DM. Empagliflozin inhibits autophagy and mitigates airway inflammation and remodelling in mice with ovalbumin-induced allergic asthma. Eur J Pharmacol 2023;950:175701.

Lodi S, Waheed A, Jehangir A, Naeem U, Khan SA, Iftikhar J. Immunomodulatory effect of betulinic acid in ovalbumin induced airway inflammation in male mice. J Islamic Int Med Coll 2019:14(2):86–90.

León B. Understanding the development of Th2 cell-driven allergic airway disease in early life. Front Allergy 2023;3:1080153.

Kamaraj Y, Dhayalan S, Chinnaiyan U, Kumaresan V, Subramaniyan S, Kumar D, et al. Triterpenoid compound betulin attenuates allergic airway inflammation by modulating antioxidants, inflammatory cytokines and tissue transglutaminase in ovalbumin-induced asthma mice model. J Pharm Pharmacol 2021;73(7):968–78.

Zaidi A, Srivastava AK, Parveen K. Role of nelumbo nucifera (LOTUS) stem as immunity booster and anti-inflammatory food. Era J Med Res 2021;8(2):1–5.

Nagori K, Nakhate KT, Yadav K, Ajazuddin, Pradhan M. Unlocking the Therapeutic Potential of Medicinal Plants for Alzheimer’s Disease: Preclinical to Clinical Trial Insights. Future Pharmacol 2023;3(4):877–907.

Faustino C, Pinheiro L, Duarte N. Triterpenes as potential drug candidates for rheumatoid arthritis treatment. Life (Basle) 2023;13(7):1514.

Jung DH, Lee A, Hwang YH, Jung MA, Pyun BJ, Lee JY, et al. Therapeutic effects of Pulsatilla koreana Nakai extract on ovalbumin-induced allergic rhinitis by inhibition of Th2 cell activation and differentiation via the IL-4/STAT6/GATA3 pathway. Biomed Pharmacother 2023;162:114730.

Kaushik A, Singh DP, Sahu M, Kumar A, Pratibha, Pandey P, et al. Protective effect of Achyranthes aspera against compound 48/80, histamine and ovalbumin-induced allergic disorders in murine model. Mol Biol Rep 2024;51(1):202.

Shaban P, Honari N, Erfanian N, Hosseini M, Safarpour H, Nasseri S. Anti-inflammatory Effects of Ziziphus Jujube Mill on LPS-induced Acute Lung Injury in Mice. Iran J Allergy Asthma Immunol 2023;22(3):281–9.

Pimentel VD, Acha BT, Gomes GF, de Sousa Cardoso JL, da Costa CL, Batista NJ, et al. Anti-inflammatory effect of Anadenanthera colubrina var. cebil (Griseb.) Altschul in experimental elastase-induced pulmonary emphysema in rats. J Ethnopharmacol 2024;332:118216.

Downloads

Published

31-12-2024

How to Cite

1.
Khan SA, Nawaz Q, Tahir M, Ahmed S, Khan MJ, Zaman S. EXPLORING BETULINIC ACID: A PROMISING THERAPY FOR ASTHMA IN MALE MICE. Pak J Phsyiol [Internet]. 2024 Dec. 31 [cited 2025 Jan. 10];20(4):40-3. Available from: https://pjp.pps.org.pk/index.php/PJP/article/view/1725